Price cut causes Invokana withdrawal

Janssen-Cilag has removed INVOKANA (canagliflozin) from the PBS effective from 1 August 2015. The company was requested by the Department of Health, to either take a significant price reduction of close to 40% on Invokana, or face the medicine being removed from the PBS. A price cut of this magnitude would result in Invokana no